Cargando…

Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma

Melanoma is the least common form of skin cancer and is associated with the highest mortality. Where melanoma is mostly unresponsive to conventional therapies (e.g., chemotherapy), BRAF inhibitor treatment has shown improved therapeutic outcomes. Photodynamic therapy (PDT) relies on a light-activate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biteghe, Fleury Augustin Nsole, Chalomie, Nyangone Ekome Toung, Mungra, Neelakshi, Vignaux, Guillaume, Gao, Nan, Vergeade, Aurelia, Okem, Ambrose, Naran, Krupa, Ndong, Jean De La Croix, Barth, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555584/ https://www.ncbi.nlm.nih.gov/pubmed/32899183 http://dx.doi.org/10.3390/biomedicines8090327

Ejemplares similares

Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies
por: Biteghe, Fleury Augustin Nsole, et al.
Publicado: (2020)

Recent advances in immunotherapies against infectious diseases
por: Ramamurthy, Dharanidharan, et al.
Publicado: (2020)

Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells
por: Mungra, Neelakshi, et al.
Publicado: (2019)

CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate
por: Mungra, Neelakshi, et al.
Publicado: (2023)

Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells
por: Huysamen, Allan M., et al.
Publicado: (2023)

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Draft Genome Sequences of Three Bacillus Species from South African Marine Sponges
por: van Zyl, Leonardo Joaquim, et al.
Publicado: (2016)

Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases
por: Naran, Krupa, et al.
Publicado: (2018)

Applications of SNAP‐tag technology in skin cancer therapy
por: Padayachee, Eden Rebecca, et al.
Publicado: (2019)

TIM-3: a tumor-associated antigen beyond checkpoint inhibition?
por: Barth, Stefan, et al.
Publicado: (2022)

Human Granzyme B Based Targeted Cytolytic Fusion Proteins
por: Hlongwane, Precious, et al.
Publicado: (2018)

Human MAP Tau Based Targeted Cytolytic Fusion Proteins
por: Akinrinmade, Olusiji A., et al.
Publicado: (2017)

CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL
por: Jordaan, Sandra, et al.
Publicado: (2017)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1
por: de la Croix Ndong, Jean, et al.
Publicado: (2014)

Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
por: Jordaan, Sandra, et al.
Publicado: (2018)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

Immunotherapy of melanoma
por: Haanen, John B.A.G.
Publicado: (2013)

Melanoma immunotherapy
por: Garg, Abhishek D., et al.
Publicado: (2015)

Immunotherapy of melanoma
por: Lugowska, Iwona, et al.
Publicado: (2018)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

The delicate balance of melanoma immunotherapy
por: Gyorki, David E, et al.
Publicado: (2013)

Cancer immunology and melanoma immunotherapy
por: Linck, Rudinei Diogo Marques, et al.
Publicado: (2017)

The age of enlightenment in melanoma immunotherapy
por: Albertini, Mark R.
Publicado: (2018)

The use of immunotherapy in the treatment of melanoma
por: Achkar, Tala, et al.
Publicado: (2017)

Current application of immunotherapy in melanoma
por: Xie, Ruxin, et al.
Publicado: (2023)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Progress of immunotherapy in the treatment of malignant melanoma.
por: Ariyan, S.
Publicado: (1975)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Immunotherapy in the management of melanoma: current status
por: Alston, Dylan, et al.
Publicado: (2013)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018)

Targeted Therapy and Immunotherapy for Melanoma in Japan
por: Namikawa, Kenjiro, et al.
Publicado: (2019)

Anthropometry in the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Cutaneous melanoma and the immunotherapy revolution (Review)
por: Leonardi, Giulia C., et al.
Publicado: (2020)

Targeting regulatory T cells for immunotherapy in melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Immunotherapy for Non-melanoma Skin Cancer
por: Shalhout, Sophia Z., et al.
Publicado: (2021)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Editorial of special focus on melanoma immunotherapy
por: Rossi, Ernesto
Publicado: (2022)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

El pensamiento en la Edad Media /
por: Vignaux, Paul
Publicado: (1954)

Cannot write session to /tmp/vufind_sessions/sess_d803nfvkb3q5afai5vrm1a8iv2